Total Payments
$46,168
2024 Payments
$1,845
Companies
60
Transactions
538
Medicare Patients
5,730
Medicare Billing
$524,642
Payment Breakdown by Category
Other$26,331 (57.0%)
Food & Beverage$10,665 (23.1%)
Travel$5,839 (12.6%)
Consulting$3,188 (6.9%)
Education$145.07 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,106 | 4 | 37.1% |
| Food and Beverage | $10,665 | 491 | 23.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $9,000 | 3 | 19.5% |
| Travel and Lodging | $5,839 | 30 | 12.6% |
| Consulting Fee | $3,188 | 1 | 6.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $225.00 | 1 | 0.5% |
| Education | $145.07 | 8 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teleflex LLC | $32,124 | 19 | $0 (2024) |
| Boston Scientific Corporation | $2,996 | 59 | $0 (2024) |
| Corindus Inc. | $1,897 | 9 | $0 (2018) |
| Abbott Laboratories | $1,433 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $737.98 | 59 | $0 (2024) |
| ABIOMED | $586.92 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $556.42 | 38 | $0 (2024) |
| Cardiovascular Systems Inc. | $497.56 | 21 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $493.76 | 24 | $0 (2024) |
| Amgen Inc. | $338.64 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,845 | 71 | Abbott Laboratories ($391.16) |
| 2023 | $10,745 | 42 | Teleflex LLC ($9,692) |
| 2022 | $8,881 | 36 | Teleflex LLC ($7,993) |
| 2021 | $526.51 | 9 | Teleflex LLC ($225.00) |
| 2020 | $3,994 | 43 | Teleflex LLC ($2,877) |
| 2019 | $13,718 | 103 | Teleflex LLC ($11,311) |
| 2018 | $3,605 | 115 | Corindus Inc. ($1,897) |
| 2017 | $2,854 | 119 | Abbott Laboratories ($915.16) |
All Payment Transactions
538 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Cardiovascular | ||||||
| 11/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.92 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/21/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.18 | General |
| 11/19/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Genetic Disease | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $99.70 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Recon-Skin and Wound | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $29.08 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.37 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.18 | General |
| 10/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $13.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: DIABETES | ||||||
| 10/01/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Not Applicable | ||||||
| 09/13/2024 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $173.94 | General |
| Category: Heart Failure | ||||||
| 09/13/2024 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $147.55 | General |
| Category: Heart Failure | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2024 | Philips North America LLC | (BQ9) Coronary IVUS (Device) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: Medical Device | ||||||
| 08/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,251 | 1,794 | $337,393 | $104,951 |
| 2022 | 27 | 1,251 | 1,725 | $345,714 | $108,973 |
| 2021 | 33 | 1,715 | 2,350 | $531,585 | $170,424 |
| 2020 | 29 | 1,513 | 2,334 | $467,339 | $140,293 |
Total Patients
5,730
Total Services
8,203
Medicare Billing
$524,642
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 409 | 482 | $86,446 | $37,368 | 43.2% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 27 | 34 | $50,184 | $12,802 | 25.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 46 | 48 | $36,336 | $7,694 | 21.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 52 | 173 | $10,207 | $6,332 | 62.0% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 17 | 100 | $30,000 | $5,425 | 18.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 86 | 95 | $14,250 | $4,402 | 30.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 39 | $8,112 | $3,774 | 46.5% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 41 | 48 | $11,424 | $3,154 | 27.6% |
| 93460 | Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 12 | 13 | $12,389 | $2,872 | 23.2% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 15 | 16 | $13,664 | $2,681 | 19.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $5,976 | $2,386 | 39.9% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 37 | 41 | $5,699 | $2,122 | 37.2% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 62 | 135 | $10,395 | $1,948 | 18.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 43 | 96 | $7,776 | $1,946 | 25.0% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 20 | 87 | $5,481 | $1,533 | 28.0% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2023 | 15 | 15 | $5,265 | $1,396 | 26.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 136 | 136 | $5,440 | $1,205 | 22.2% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 24 | 24 | $2,975 | $1,194 | 40.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 19 | $2,071 | $1,121 | 54.1% |
| 93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | Office | 2023 | 20 | 42 | $6,720 | $987.12 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $1,778 | $801.36 | 45.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $1,430 | $781.43 | 54.6% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 75 | 85 | $2,550 | $760.84 | 29.8% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 15 | 15 | $825.00 | $264.75 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 368 | 435 | $70,905 | $36,043 | 50.8% |
About Dr. Scott Sharp, MD
Dr. Scott Sharp, MD is a Cardiovascular Disease healthcare provider based in Indianapolis, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518966712.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Sharp, MD has received a total of $46,168 in payments from pharmaceutical and medical device companies, with $1,845 received in 2024. These payments were reported across 538 transactions from 60 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($17,106).
As a Medicare-enrolled provider, Sharp has provided services to 5,730 Medicare beneficiaries, totaling 8,203 services with total Medicare billing of $524,642. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Indianapolis, IN
- Active Since 07/19/2005
- Last Updated 06/14/2021
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1518966712
Products in Payments
- GUIDELINER (Device) $17,698
- CATHETERS - ARROW (Device) $11,202
- CATHETER - TURNPIKE (Device) $2,877
- CardioMEMS HF System (Device) $885.31
- CROSSBOSS (Device) $774.95
- XARELTO (Drug) $737.98
- GENERAL - VASCULAR ACCESS (Device) $715.98
- Impella (Device) $586.92
- ENTRESTO (Drug) $502.37
- ELIQUIS (Drug) $338.80
- 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) $321.49
- BRILINTA (Drug) $301.23
- AVVIGO Guidance System (Device) $289.05
- Peripheral Orbital Atherectomy System (Device) $268.50
- GUARDIAN II HEMOSTASIS VALVE (Device) $225.00
- Corlanor (Drug) $215.15
- Coronary Orbital Atherectomy System (Device) $204.76
- JARDIANCE (Drug) $204.23
- VERQUVO (Drug) $201.92
- FARXIGA (Drug) $192.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Indianapolis
Eric Prystowsky, Md, MD
Cardiovascular Disease — Payments: $1.7M
Cardiovascular Disease $1.7M
Dr. Vijay Rao, M.d., Ph.d, M.D., PH.D
Cardiovascular Disease — Payments: $431,147
Cardiovascular Disease $431,147
James Hermiller, Md, MD
Cardiovascular Disease — Payments: $380,511
Cardiovascular Disease $380,511
Dr. Atul Chugh, M.d, M.D
Cardiovascular Disease — Payments: $213,637
Cardiovascular Disease $213,637
Noel Dasgupta, Md, MD
Cardiovascular Disease — Payments: $164,975
Cardiovascular Disease $164,975
Michael Ball, Md, MD
Cardiovascular Disease — Payments: $131,315
Cardiovascular Disease $131,315